Craneware PLC warned that its full-year revenue and earnings will fall short of market expectations due to slower-than-expected conversion of 340B pharmacy-related opportunities. The company expects revenue between $205 million and $208 million and adjusted EBITDA of $65 million to $67 million for the year ending June 30, 2026, roughly flat compared to the previous year. The delay was caused by timing issues with 340B activity and postponed enterprise contracts now expected to contribute in FY27. Despite the setback, Craneware remains optimistic about long-term opportunities and will update investors with full-year results in September 2026.
Virtuals Protocol has introduced customizable tokenized indexes on the Robinhood Chain, allowing users to combine multiple assets into a single token. This innovation enables users to create and manage their own asset baskets and earn fees when other...
US spot Bitcoin ETFs saw net inflows of $107.8 million on Wednesday, while Ethereum ETFs attracted $53.8 million, signaling renewed institutional interest in crypto funds. Since their launch in January 2024, Bitcoin ETFs have accumulated over $51 bil...
Kaia has signed a strategic partnership with Xilo Labs to integrate Mochi, an onchain asset management platform, into Kaia's ecosystem. This collaboration allows users to invest stablecoins into diversified portfolios backed by tokenized real-world a...
Bitcoin's price surged to nearly $65,000 following softer-than-expected U.S. inflation data for June, easing fears of Federal Reserve rate hikes. However, on-chain data reveals two main groups of investors—long-term holders who bought near last year'...
Bitcoin miners are experiencing declining revenue as the network's hash rate and mining difficulty fall, reflecting a shift of miners into AI infrastructure. Despite this stress, miners are accumulating Bitcoin, with reserves increasing by 1%, signal...
